## Abstract Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years. Mutations in the gene encoding leucine‐rich repeat kinase‐2 (__LRRK2__) have recently been linked to autosomal dominant, late‐onset PD that is cl
✦ LIBER ✦
α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of parkinson disease
✍ Scribed by Jason P. Covy; Benoit I. Giasson
- Book ID
- 116780241
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 580 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0161-813X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Leucine-rich repeat kinase 2 (LRRK2): A
✍
Payal N. Gandhi; Shu G. Chen; Amy L. Wilson-Delfosse
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 209 KB
The role of leucine-rich repeat kinase 2
✍
Cookson, Mark R.
📂
Article
📅
2010
🏛
Nature Publishing Group
🌐
English
⚖ 358 KB
Mood and cognition in leucine-rich repea
✍
Vicki Shanker; Mark Groves; Gary Heiman; Christina Palmese; Rachel Saunders-Pull
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 110 KB
## Abstract The behavioral and cognitive features of the leucine‐rich repeat kinase G2019S mutation in Parkinson's disease in the Ashkenazi Jewish population are not well described; therefore, we sought to more systematically characterize these features using a semistructured psychiatric interview
From The Cover: Parkinson's disease-asso
✍
West, A. B.
📂
Article
📅
2005
🏛
National Academy of Sciences
🌐
English
⚖ 514 KB
A comparative study of Parkinson's disea
✍
Trinh, Joanne; Amouri, Rim; Duda, John E.; Morley, James F.; Read, Matthew; Dona
📂
Article
📅
2014
🏛
Elsevier Science
🌐
English
⚖ 481 KB
The G2019S pathogenic mutation disrupts
✍
Jason P. Covy; Benoit I. Giasson
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 496 KB